

Reuters World News
Reuters
Everything you need to know about your world in 10 minutes. Go straight to the source with a ten-minute news briefing by Reuters frontline journalists. Join host Kim Vinnell as she takes you around the world every day.
Episodes
Mentioned books
Dec 1, 2023 • 13min
A New York hit job, U.S. bishops back oil and the Supreme Court's big decision
Indian official accused of assassination plot in New York, U.S. bishops' investment in oil and gas despite climate talks, Supreme Court case with implications for government's rules, Gaza truce update, and Elon Musk's criticism of advertisers.
Nov 29, 2023 • 13min
Truce talks, Netanyahu’s future, Ukraine poisoning and Haley’s moment
Qatari mediators attempt to broker another truce extension in Gaza; Israeli hostages re-enter society with political ramifications; Ukraine's top spymaster's wife poisoned; Nikki Haley's moment in the White House race.

Nov 28, 2023 • 13min
Israel’s Hamas targets, Ukraine war fatigue and Biden gets aggressive
Truce extended between Israel and Hamas, but Israel still aims to wipe out the militant group. Analysis on Hamas targets and Israel's military campaign. Various news topics including North Korea's spy satellite and journalist's detention. Impact of war on families in Ukraine and challenges in mobilization. Bidenomics not resonating with voters, leading to shift in strategy towards targeting Donald Trump.

Nov 27, 2023 • 13min
Truce extension hopes, Musk in Israel, Trump’s plans and the Mexican dream
Elon Musk visits Israel amidst anti-Semitism accusations. Truce holds between Israel and Hamas, with potential plans to extend allowing more hostages to be released. Former President Trump discusses plans for stricter immigration policies. Migrants reevaluate their American dream, finding success in Mexico.
Nov 25, 2023 • 17min
The Crown, the cabinet and the UK's legacy of slavery
George Smith, descendant of a British politician who profited from slavery, discusses the investigation into the links between his family and the UK's legacy of slavery. The podcast explores the calls for reparations, the challenges of researching Caribbean slavery, and the reactions of King Charles and Jeremy Hunt to their connections with slavery.

Nov 24, 2023 • 12min
Gaza truce, radicalization fears, Black Friday deals and OpenAI’s breakthrough
Ceasefire in Gaza with hostage releases expected. Concerns about Islamist attacks in Europe. Cheapest holiday gift season for US shoppers. Alarming AI breakthrough called Q-Star by OpenAI.

Nov 22, 2023 • 12min
Hostage deal, Altman 2.0, Dutch uncertainty and Thanksgiving politics
Sam Altman, CEO of OpenAI, discusses the recent hostage deal between Israel and Hamas, his return as CEO of OpenAI, the tight race in the Netherlands election, and navigating challenging conversations about the Israeli-Palestinian conflict.
Nov 21, 2023 • 12min
Hamas’ truce, Gaza rains, Ukraine aid and Cruise’s problems
The chief of Hamas reveals that a truce agreement with Israel is nearing, while Gaza prepares for winter rains. The Ukrainian president turns to Fox CEO Lachlan Murdoch for aid. Other topics include OpenAI, the challenges faced by EV startup Cruise, and more.
Nov 20, 2023 • 13min
Altman’s Microsoft move, Argentina’s shock, hostage hopes and TikTok dupes
Sam Altman, former CEO of OpenAI, discusses his unexpected move to Microsoft. Efforts to free hostages in Gaza and Argentina's election results are also covered. There is a chapter on the passing of Rosalind Carter, dismissal of the Ukrainian medical forces commander, surge of Japanese shares, and rise of brand duplicates promoted on TikTok. The impact of dupes on big brands and market response is explored, including campaigns and potential transition of dupeshoppers into brand shoppers.
Nov 18, 2023 • 26min
Who gets the weight loss drugs when supply doesn’t meet demand?
Global demand and supply of weight loss drugs, challenges in accessing Ozempic in the UK, discussion on brands and mechanisms of weight loss drugs, research on potential heart benefits, health disparities in access to weight loss drugs


